CVRx Announces CMS Reassignment Of Barostim Implant Procedure To MS-DRG 276 With $43,000 National Average Payment In FY 2025 Medicare Hospital Inpatient Prospective Payment System
Portfolio Pulse from Benzinga Newsdesk
CVRx announced that the Centers for Medicare & Medicaid Services (CMS) has reassigned the Barostim implant procedure to MS-DRG 276 with a national average payment of $43,000 in the FY 2025 Medicare Hospital Inpatient Prospective Payment System. The new payment will be effective starting October 1, 2024.
August 02, 2024 | 12:06 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
CVRx's Barostim implant procedure has been reassigned to MS-DRG 276 with a national average payment of $43,000 in the FY 2025 Medicare Hospital Inpatient Prospective Payment System. This reassignment is expected to positively impact CVRx's revenue starting October 1, 2024.
The reassignment of the Barostim implant procedure to MS-DRG 276 with a higher national average payment is likely to increase CVRx's revenue. This change will be effective from October 1, 2024, providing a clear timeline for the expected financial impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100